PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.36%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-39.33%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-66.67%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-66.67%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-75.16%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-75.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-75.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.07%
Slight or no buybacks while AR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
0.27%
Dividend growth of 0.27% while AR is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
6.77%
OCF growth at 75-90% of AR's 7.56%. Bill Ackman would demand better working capital management or cost discipline.
255.33%
FCF growth above 1.5x AR's 15.38%. David Dodd would verify if the firm’s strategic investments yield superior returns.
161.72%
10Y revenue/share CAGR at 50-75% of AR's 226.56%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
69.53%
5Y revenue/share CAGR similar to AR's 76.73%. Walter Schloss might see both companies benefiting from the same mid-term trends.
9.12%
Positive 3Y CAGR while AR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
426.71%
10Y OCF/share CAGR above 1.5x AR's 83.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
200.57%
5Y OCF/share CAGR at 75-90% of AR's 266.41%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
-7.17%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-2.45%
Negative 10Y net income/share CAGR while AR is at 196.15%. Joel Greenblatt sees a major red flag in long-term profit erosion.
17.10%
Below 50% of AR's 129.17%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-87.77%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
248.34%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
160.40%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.09%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
899.39%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
701.10%
Dividend/share CAGR of 701.10% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
305.19%
3Y dividend/share CAGR of 305.19% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
6.92%
Our AR growth while AR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
32.46%
Inventory growth of 32.46% while AR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
1.58%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.69%
BV/share growth above 1.5x AR's 1.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.34%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
41.18%
SG&A growth well above AR's 24.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.